SVB Leerink Maintains Outperform on Repligen, Lowers Price Target to $200

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $230 to $200.

SVB Leerink analyst Puneet Souda maintains Repligen (NASDAQ:RGEN) with a Outperform and lowers the price target from $230 to $200.

Total
0
Shares
Related Posts
Read More

EPR Properties Said it is Not in Current Negotiations with Regal or Cineworld Regarding their Obligations to EPR Properties

On August 17, 2022, Cineworld Group plc ("Cineworld"), the parent entity of entities that lease EPR Properties' Regal theatres, provided an update regarding its current trading, liquidity position and capital structure wherein Cineworld disclosed that it is "evaluating various strategic options to both obtain additional liquidity and potentially restructure its balance sheet through a comprehensiv

EPR